This study explored the relative impact of general medical conditions and psychopathology on the current and lifetime use of anxiolytic and/or hypnotic drugs by general hospital in patients.
One hundred and five consecutive patients, admitted to an internal medicine department, were assessed by a structured interview about current and lifetime use of anxiolytic and/or hypnotic drugs, and with somatic and psychopathology scales.
Eighty percent of patients reported using anxiolytics and/or hypnotics at least once in a lifetime, 62.9% in the last year, 55.2% in the last 3 months, and 42.9% in the last week.
Correlations were found between drug use and current levels of anxiety and depression, but not somatic pathology.
Psychological suffering appeared to be a major determinant for anxiolytic and/or hypnotic use by patients with general medical conditions.
Consumption rates were higher than in the general population, but there was no direct link between somatic morbidity and drug use.
Mots-clés Pascal : Hôpital général, Hospitalisation, Chimiothérapie, Tranquillisant, Hypnotique, Psychotrope, Trouble psychiatrique, Prescription médicale, Santé mentale, France, Europe, Homme, Maladie somatique
Mots-clés Pascal anglais : General hospital, Hospitalization, Chemotherapy, Tranquillizer, Hypnotic, Psychotropic, Mental disorder, Medical prescription, Mental health, France, Europe, Human, Somatic disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0349166
Code Inist : 002B02B03. Création : 14/12/1999.